Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 40

Similar articles for PubMed (Select 18990302)

1.

Does blood glucose control improve vascular outcomes in patients with type 2 diabetes?

Stanton RC.

Curr Diab Rep. 2008 Dec;8(6):461-3. No abstract available.

PMID:
18990302
2.

Defining the importance of daily glycemic control and implications for type 2 diabetes management.

Bode BW.

Postgrad Med. 2009 Sep;121(5):82-93. doi: 10.3810/pgm.2009.09.2055. Review.

PMID:
19820277
3.

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee.

Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25.

PMID:
19633827
4.

Trials review: cardiovascular outcome with intensive glycemic control and implications for patients with type 2 diabetes.

Brown SH, Abdelhafiz AH.

Postgrad Med. 2009 Sep;121(5):31-41. doi: 10.3810/pgm.2009.09.2050. Review.

PMID:
19820272
5.

Mobile diabetes intervention study: testing a personalized treatment/behavioral communication intervention for blood glucose control.

Quinn CC, Gruber-Baldini AL, Shardell M, Weed K, Clough SS, Peeples M, Terrin M, Bronich-Hall L, Barr E, Lender D.

Contemp Clin Trials. 2009 Jul;30(4):334-46. doi: 10.1016/j.cct.2009.02.004. Epub 2009 Feb 27.

PMID:
19250979
6.

[Treatment of diabetes in metabolic syndrome].

Pelikánova T.

Vnitr Lek. 2009 Jul-Aug;55(7-8):637-45. Review. Czech.

PMID:
19731868
7.

A randomized behavioural trial targeting glycaemic index improves dietary, weight and metabolic outcomes in patients with type 2 diabetes.

Gutschall MD, Miller CK, Mitchell DC, Lawrence FR.

Public Health Nutr. 2009 Oct;12(10):1846-54. doi: 10.1017/S1368980008004680. Epub 2009 Jan 23.

PMID:
19161649
8.

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

Højberg PV, Vilsbøll T, Rabøl R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S.

Diabetologia. 2009 Feb;52(2):199-207. doi: 10.1007/s00125-008-1195-5. Epub 2008 Nov 27.

PMID:
19037628
9.

Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial.

French DP, Wade AN, Yudkin P, Neil HA, Kinmonth AL, Farmer AJ.

Diabet Med. 2008 Oct;25(10):1218-28. doi: 10.1111/j.1464-5491.2008.02569.x.

PMID:
19046201
10.

Adhering to a t'ai chi program to improve glucose control and quality of life for individuals with type 2 diabetes.

Song R, Ahn S, Roberts BL, Lee EO, Ahn YH.

J Altern Complement Med. 2009 Jun;15(6):627-32. doi: 10.1089/acm.2008.0330.

PMID:
19500007
11.

Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.

Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P; IMPROVE Study Group Expert Panel.

Curr Med Res Opin. 2009 Nov;25(11):2643-54. doi: 10.1185/03007990903276745.

PMID:
19751116
12.

Targets and tactics: the relative importance of HbA, fasting and postprandial plasma glucose levels to glycaemic control in type 2 diabetes.

Woo V, Shestakova MV, Ørskov C, Ceriello A.

Int J Clin Pract. 2008 Dec;62(12):1935-42. doi: 10.1111/j.1742-1241.2008.01941.x. Review.

PMID:
19166440
13.

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study.

Du X, Ninomiya T, de Galan B, Abadir E, Chalmers J, Pillai A, Woodward M, Cooper M, Harrap S, Hamet P, Poulter N, Lip GY, Patel A; ADVANCE Collaborative Group.

Eur Heart J. 2009 May;30(9):1128-35. doi: 10.1093/eurheartj/ehp055. Epub 2009 Mar 11.

14.

Compensatory beliefs about glucose testing are associated with low adherence to treatment and poor metabolic control in adolescents with type 1 diabetes.

Rabiau MA, Knäuper B, Nguyen TK, Sufrategui M, Polychronakos C.

Health Educ Res. 2009 Oct;24(5):890-6. doi: 10.1093/her/cyp032. Epub 2009 Jul 17.

15.

Diabetes treatment and control: the effect of public health insurance for the poor in Mexico.

Sosa-Rubí SG, Galárraga O, López-Ridaura R.

Bull World Health Organ. 2009 Jul;87(7):512-9.

16.

Implications of the ADVANCE study for clinical practice.

Zannad F.

J Hypertens Suppl. 2008 Sep;26(3):S29-32. Review.

PMID:
19363850
17.
18.

Use of short-term real-time continuous glucose monitoring in type 1 diabetes patients on continuous intraperitoneal insulin infusion: a feasibility study.

Logtenberg SJ, Kleefstra N, Groenier KH, Gans RO, Bilo HJ.

Diabetes Technol Ther. 2009 May;11(5):293-9. doi: 10.1089/dia.2008.0088.

PMID:
19425877
19.

Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes.

Bibra Hv, Siegmund T, Ceriello A, Volozhyna M, Schumm-Draeger PM.

Horm Metab Res. 2009 Feb;41(2):109-15. doi: 10.1055/s-0028-1112136. Epub 2009 Feb 12.

PMID:
19214920
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk